Publicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (56)

2024

  1. Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study

    The Lancet Microbe, Vol. 5, Núm. 4, pp. e390-e399

2023

  1. A new approach to prostate cancer screening

    Advances in Laboratory Medicine, Vol. 4, Núm. 3, pp. 207-211

  2. Cardiovascular-related proteomic changes in ECFCs exposed to the serum of COVID-19 patients

    International Journal of Biological Sciences, Vol. 19, Núm. 6, pp. 1664-1680

  3. Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia: Post-Hoc Analysis of a Multicenter Observational Cohort

    Antibiotics, Vol. 12, Núm. 1

  4. Detection of High Level of Co-Infection and the Emergence of Novel SARS CoV-2 Delta-Omicron and Omicron-Omicron Recombinants in the Epidemiological Surveillance of Andalusia

    International journal of molecular sciences, Vol. 24, Núm. 3

  5. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    The Lancet Regional Health - Europe, Vol. 34

  6. Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin

    Biomedicine and Pharmacotherapy, Vol. 168

  7. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

    Frontiers in Microbiology, Vol. 14

  8. Una nueva perspectiva en el cribado del cáncer de próstata

    Advances in Laboratory Medicine, Vol. 4, Núm. 3, pp. 212-217

  9. Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

    Frontiers in Molecular Biosciences, Vol. 10

2022

  1. Identification of myosin light chain protein as a major fish allergen

    Clinical and Experimental Allergy

  2. Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: First report in Europe

    Journal of Hepatology, Vol. 77, Núm. 2, pp. 326-331

  3. Post-COVID Complications after Pressure Ulcer Surgery in Patients with Spinal Cord Injury Associate with Creatine Kinase Upregulation in Adipose Tissue

    Cells, Vol. 11, Núm. 8

  4. Pseudomonas aeruginosa Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development—Results from the PRO-BAC Cohort

    Antibiotics, Vol. 11, Núm. 6

  5. Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients

    Molecular Therapy - Nucleic Acids, Vol. 29, pp. 76-87

  6. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo

    Molecular Medicine, Vol. 28, Núm. 1

2021

  1. Epidemiologic changes in bloodstream infections in Andalucía (Spain) during the last decade

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 283.e9-283.e16

  2. Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

    Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810

  3. Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015

    Emerging Infectious Diseases, Vol. 27, Núm. 1, pp. 26-35

  4. Limited Value of Single Sampling for IgM Antibody Determination as a Diagnostic Approach for Acute Hepatitis E Virus Infection

    Microbiology Spectrum, Vol. 9, Núm. 1, pp. 1-5